Pathophysiological bases of comorbidity in migraine

C Altamura, I Corbelli, M De Tommaso… - Frontiers in Human …, 2021 - frontiersin.org
Despite that it is commonly accepted that migraine is a disorder of the nervous system with a
prominent genetic basis, it is comorbid with a plethora of medical conditions. Several studies …

Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome

S Sciascia, G Sanna, V Murru… - Thrombosis and …, 2014 - thieme-connect.com
Antibodies to prothrombin are detected by directly coating prothrombin on irradiated ELISA
plates (aPT) or by using the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …

[HTML][HTML] Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC …

A Vandevelde, W Chayoua, B de Laat… - Journal of Thrombosis …, 2022 - Elsevier
Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in …

H Shi, H Zheng, YF Yin, QY Hu, JL Teng… - Clinical Chemistry and …, 2018 - degruyter.com
Background: The aim of the study was to determine the prevalence and clinical associations
of antiphosphatidylserine/prothrombin antibodies (aPS/PT) with thrombosis and pregnancy …

[HTML][HTML] Tetra positive thrombotic antiphospholipid syndrome: major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity

MG Cattini, E Bison, E Pontara, C Cheng… - Journal of Thrombosis …, 2020 - Elsevier
Background The concurrent presence of lupus anticoagulant, anticardiolipin, and anti β2‐
glycoprotein I antibodies (triple positive profile) identifies patients at high risk of …

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

PL Meroni, CB Chighizola, F Rovelli… - Arthritis research & …, 2014 - Springer
The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular
thrombosis or miscarriages but includes additional manifestations that cannot be explained …

Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A …

R Zhu, CY Cheng, Y Yang, G Denas, V Pengo - Thrombosis Research, 2022 - Elsevier
Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

V Pengo, T Del Ross, A Ruffatti, E Bison, MG Cattini… - Thrombosis research, 2018 - Elsevier
Background Whether antibodies directed to β2-Glycoprotein I (aβ2GPI) are responsible for
LA activity is not well defined. However, in the absence of such antibodies the molecule …

Anti-phosphatidylserine/prothrombin antibodies at two points: correlation with lupus anticoagulant and thrombotic risk

N Egri, C Bentow, L Rubio, GL Norman… - Frontiers in …, 2021 - frontiersin.org
Antibodies to phospholipids (aPL) and associated proteins are a hallmark in the diagnosis of
anti-phospholipid syndrome (APS). Those included in the classification criteria are the lupus …

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome

A Hoxha, E Mattia, M Tonello, C Grava… - Clinical Chemistry and …, 2017 - degruyter.com
Background: Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be
considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study …